| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |